Exclusive stubby use may lower residual limb muscle volume. The finding is about rehabilitation planning, not the value of the device.
Researchers studying bilateral transfemoral and through-knee amputees found that using nonarticulated prostheses exclusively, rather than alongside full-length articulated devices, may be associated with lower residual limb muscle volume. What that finding means for how rehabilitation plans should account for device use patterns.

The O&P EDGE reported on a new study examining the use patterns of nonarticulated prostheses, commonly called stubbies, in people with bilateral transfemoral or through-knee amputations. The finding: exclusive reliance on stubbies, rather than using them alongside full-length articulated prostheses, may be associated with lower residual limb muscle volume.
That headline warrants a bit of unpacking before jumping to conclusions, because the finding is not a case against stubbies. It is a case for how rehabilitation programs think about what exclusive device use does to residual limb tissue over time.
What stubbies are and why bilateral amputees use them
Stubbies are short, nonarticulated prostheses with no knee joints. The foot components sit directly below the residual femur or knee remnant. They position the user much closer to the ground than standard prostheses, which lowers the center of gravity, reduces the distance of a potential fall, and significantly decreases the energy cost of walking compared to full-length bilateral prosthetics.
For people with bilateral transfemoral amputation specifically, stubbies often function as the first ambulation device used in rehabilitation. The energy demands of walking on two full-length above-knee prosthetics, each requiring active hip extension against the prosthetic knee, are substantial. Stubbies sidestep the problem by eliminating the knee entirely.
Many bilateral amputees use stubbies permanently for indoor mobility and transition to full-length devices for outdoor activity, work, or situations where height matters functionally. Others find that stubbies meet enough of their mobility needs that they use them as their primary or sole device.
What muscle volume has to do with it
After amputation, residual limb muscles do not have the distal attachments and functional loading they had before. Without regular resistance through the limb, they atrophy. This is a well-documented process, and it happens even in people who are active prosthetic users: the loading patterns through a prosthetic socket are different from the loading patterns in a biological limb, and that difference affects how muscles maintain or lose volume over time.
Muscle volume in the residual limb matters for several reasons. Socket fit is one: a prosthetic socket is designed for a specific limb shape and size. Significant muscle atrophy changes the geometry of the residual limb, which can lead to fit problems, pistoning, pressure sores, or the need for socket replacement. Residual limb health is another: muscle bulk contributes to cushioning over bony prominences and to the overall vascular supply of the tissue. And for some people, residual limb muscle activity plays a role in prosthetic control, particularly for more advanced devices that use myoelectric signals.
What the exclusive-use finding suggests
The researchers were studying the implications of using stubbies exclusively versus using them alongside full-length articulated prostheses. The comparison matters because the two device types load the residual limb differently.
Full-length prostheses with articulating knees require more dynamic hip and residual limb engagement through the gait cycle. The muscles of the residual femur and hip extensors are doing more work, against more resistance, across a wider range of motion. With stubbies, the loading is more static and the range of motion through the residual limb during ambulation is more limited.
If exclusive stubby use is associated with lower muscle volume, the mechanism is likely reduced loading stimulus over time: the muscles that would be recruited in dynamic articulated gait are simply doing less, so they maintain less bulk. That hypothesis fits the existing science on disuse atrophy and residual limb muscle physiology.
The finding does not say stubbies cause harm. It says the loading difference between device types may have tissue-level consequences that are worth tracking and planning around.
What this means for bilateral amputees and their care teams
The useful question the research opens is not “should bilateral amputees stop using stubbies.” Stubbies are a legitimate, practical device for a population where full-length bilateral prosthetic use is genuinely demanding. The useful question is: if someone is using stubbies exclusively, is their rehabilitation plan accounting for residual limb muscle health in other ways?
That might mean supplementary exercise programming focused on hip and residual limb muscle loading. It might mean periodic imaging or physical assessment of residual limb muscle volume to catch changes early, before they create fit problems or skin issues. It might mean a clinical conversation about whether adding a full-length device, even for limited use, is practical and beneficial for a given person.
It also raises a question about how rehabilitation programs are currently monitoring this. Stubbies are prescribed, fitted, and often left to function as the patient’s primary device without systematic follow-up on what the exclusive use pattern is doing to the residual limb over months or years. If the research holds up, that monitoring gap is worth addressing.
For bilateral amputees who are currently using stubbies: this finding is not a reason to change anything without a conversation with your prosthetist and rehabilitation team. It is a reason to raise the topic, ask how your residual limb muscle health is being monitored, and understand what the plan is if volume changes over time.
The care team is the right place to work through what it means for a specific person’s situation. This is an orientation to a research finding, not individual clinical guidance.
Source notebook: This reporting draws on The O&P EDGE: Exclusive Stubby Use May Lower Muscle Volume, September 2026 ↗. We link out so you can follow the receipts.